INTERNATIONAL PATENT: TVARDI THERAPEUTICS, INC. FILES APPLICATION FOR "FORMULATIONS OF STAT3 INHIBITORS AND METHODS OF USE THEREOF"

GENEVA, March 18 -- TVARDI THERAPEUTICS, INC. (3 Sugar Creek Center Boulevard, Suite 525Sugar Land, Texas 77478) filed a patent application (PCT/US2024/045328) for "FORMULATIONS OF STAT3 INHIBITORS AND METHODS OF USE THEREOF" on Sep 05, 2024. With publication no. WO/2025/054280, the details related to the patent application was published on Mar 13, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ALIBHAI, Imran (c/o Tvardi Therapeutics, Inc.3 Sugar Creek Center Boulevard, Suite 525Sugar Land, Texas 77478), DE ACHAVAL, Sofia (c/o Tvardi Therapeutics, Inc.3 Sugar Creek Center Boulevard, Suite 5...